The U.S. Food and Drug Administration today approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex (TSC). This is a summary of a Press Release issued by the Food and Drug Administration (FDA). The link below will take you [...]
From the category archives:
